Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Pediatric Schizophrenia Efficacy and Safety Study

ClinicalTrials.gov ID: NCT01911429

Public ClinicalTrials.gov record NCT01911429. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 4:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Efficacy and Safety study of Lurasidone in pediatric patients.

Study identification

NCT ID
NCT01911429
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
327 participants

Conditions and interventions

Eligibility (public fields only)

Age range
13 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2013 (Type not available)
Primary completion
Dec 2015 (Actual)
Completion
Dec 2015 (Actual)
Last update posted
Apr 18, 2017

2013 – 2015

United States locations

U.S. sites
36
U.S. states
18
U.S. cities
36
Facility City State ZIP Site status
Harmonex Neuroscience Research Dothan Alabama 36303 —
California Pharmaceutical Research Institute, Inc Anaheim California 92804 —
Central Valley Medical Research Bakersfield California 93311 —
ProScience Research Group Culver City California 90230 —
Diligent Clinical Trials, Inc Downey California 90241 —
Collaborative Neuroscience Network, LLC Garden Grove California 92845 —
Global Clinical Trials, LLC Irvine California 92614 —
Neuropsychiatric Research Center of Orange County Orange California 92868 —
Asclepes Research Panorama City California 91402 —
CITrials, Inc. - Riverside & San Bernardino County Riverside California 92506 —
Hartford Hospital Hartford Connecticut 06106 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
Florida Clinical Research Center, LLC Bradenton Florida 34201 —
Sarkis Clinical Trials - Parent Gainesville Florida 32607 —
APG Research, LLC Orlando Florida 32803 —
Medical Research Group of Central Florida Sanford Florida 32771 —
Atlanta Center for Medical Research Atlanta Georgia 30308 —
Institute for Behavioral Medicine, LLC Smyrna Georgia 30080 —
Baber Research Group Naperville Illinois 60563 —
Lake Charles Clinical Trials, LLC Lake Charles Louisiana 70629 —
Kennedy Krieger Institute Baltimore Maryland 21205 —
Neurobehavioral Medicine Group, PLLC Bloomfield Hills Michigan 48302 —
Jersey Shore University Medical Center Neptune City New Jersey 07753 —
Manhattan Behavioral Medicine, LLC New York New York 10022 —
Finger Lakes Clinical Research Rochester New York 14618 —
Richmond Behavioral Associates Staten Island New York 10312 —
University of Cincinnati Medical Center Cincinnati Ohio 45219 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
Cutting Edge Research Group Oklahoma City Oklahoma 73116 —
Research Strategies of Memphis, LLC Memphis Tennessee 38119 —
BioBehavioral Research of Austin Austin Texas 78759 —
Pillar Clinical Research, LLC Dallas Texas 75243 —
BioBehavioral Research of Austin El Campo Texas 77437 —
Family Psychiatry of The Woodlands, P.A. The Woodlands Texas 77381 —
Aspen Clinical Research Orem Utah 84058 —
University of Virginia Charlottesville Virginia 22903 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01911429, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 18, 2017 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01911429 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →